Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

BACKGROUND. Gemcitabine and docetaxel have a broad spectrum of clinical activity in patients with carcinoma. The Sarcoma Alliance for Research Through Collaboration conducted a phase II trial of gemcitabine in combination with docetaxel in children and adults with recurrent Ewing sarcoma (EWS), oste...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Fox, Elizabeth, Patel, Shreyaskumar, Wathen, J. Kyle, Schuetze, Scott, Chawla, Sant, Harmon, David, Reinke, Denise, Chugh, Rashmi, Benjamin, Robert S., Helman, Lee J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2012
Soggetti:
Clinical Trial Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3316916/
https://ncbi.nlm.nih.gov/pubmed/22363068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0265
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi